CAS 169673-60-3
:6-(2-Acetamido-2-deoxy-beta-D-glucopyranosyloxy)-7-hydroxy-2H-1-benzopyran-2-one
Description:
The chemical substance known as 6-(2-Acetamido-2-deoxy-beta-D-glucopyranosyloxy)-7-hydroxy-2H-1-benzopyran-2-one, with the CAS number 169673-60-3, is a complex organic compound characterized by its structural features that include a benzopyran backbone and a glucopyranosyl moiety. This compound exhibits properties typical of flavonoids, which are known for their antioxidant activity and potential health benefits. The presence of the acetamido group suggests that it may have enhanced solubility and bioavailability. The hydroxyl groups contribute to its reactivity and ability to form hydrogen bonds, which can influence its interaction with biological systems. Additionally, the glucopyranosyl unit may facilitate interactions with specific receptors or enzymes, potentially impacting its pharmacological profile. Overall, this compound's unique structure may confer specific biological activities, making it of interest in medicinal chemistry and pharmaceutical research. Further studies would be necessary to elucidate its precise mechanisms of action and therapeutic potential.
Formula:C17H19NO9
Synonyms:- Cpa-926
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
CPA 926
CAS:<p>CPA 926 is a potent inhibitor that has shown to be effective in treating cancer. It is an analog of the kinase inhibitor, which has been found in urine samples from Chinese medicinal herbs. CPA 926 works by inhibiting kinases, which are enzymes that play a crucial role in the regulation of cell growth and division. By inhibiting these kinases, CPA 926 promotes apoptosis (programmed cell death) in cancer cells, thereby reducing tumor growth. This anticancer drug has been tested on human cancer cells and has shown promising results in pre-clinical studies. CPA 926 is a potential candidate for the development of new therapies for various types of cancer.</p>Formula:C17H19NO9Purity:Min. 95%Molecular weight:381.3 g/mol
